
- Volume 0 0
 
YO-YO PART D PREMIUMS: IS IT Rx BAIT AND SWITCH?
Many Medicare patients who signed onwith the lowest cost Part D prescriptiondrug plans last year are facing steepincreases this year, while others are seeingtheir monthly out-of-pocket premiumcharges shrink for 2007.
These yo-yo premiums—the latest wrinklein the continuing litany of concerns surroundingthe year-old Part D prescriptiondrug benefit—drew nationwide attentionwhen the provider of the least expensivedrug plans, Humana, increased monthly premiumsfor >2 million enrolled seniors by anaverage of 60%, effective January 1, 2007.
Actually, those facing only "average"premium hikes are the lucky ones.Massachusetts Medicare patients enrolledin Humana's low-cost ($7.32 per month)plan have been hit with premium hikes of130% (to $16.90), and seniors in severalMidwestern states received increases of466%. At the same time, however, the costfor Humana's low-cost "standard" Part Dcoverage is going down in 3 states—Georgia, Louisiana, and South Carolina.
Other plans, including those sponsoredby AARP, imposed much smaller premiumincreases for 2007, leading consumeractivists to accuse Humana of "bait-and-switch"Part D pricing practices. For theirpart, however, officials at Humana saidthat the increases were justified, and that,even at the higher rates, its Part D premiumsrank among the lowest of all plans inmost states.
Articles in this issue
almost 19 years ago
compounding HOTLINEalmost 19 years ago
The Good and the Bad of High Cholesterolalmost 19 years ago
Compounding Dental Applicationsalmost 19 years ago
An Overview and Update of the Controlled Substances Act of 1970almost 19 years ago
ccpa SPEAKS OUT: AMP Definition "Defines" Pharmacists out of Medicaidalmost 19 years ago
Are We Really Ready? Preparing for Disastersalmost 19 years ago
When the Patient Won't Take the Medicinealmost 19 years ago
Community Commitment Earns RESPy Awardalmost 19 years ago
Kerr's Center Concentrates on Health and Educationalmost 19 years ago
Mandatory Periodic Breaks for Pharmacists UpheldNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































